Table 3 Predictive Ratios for Year-2 pharmacy costs for Disease, Drug Use and Cost Defined Groups.
Alternative Predictive Models | ||||||||
|---|---|---|---|---|---|---|---|---|
Dx-PM | Rx-PM | DxRx-PM | ||||||
n | Mean pharmacy expenditure Year-2 (€) | U.S. Weights | Spanish Weights | U.S. Weights | Spanish Weights | U.S. Weights | Spanish Weights | |
Medical condition groups | ||||||||
Hypertension | 16,519 | 931 | 0.773 | 0.999 | 0.856 | 0.989 | 0.864 | 1.000 |
Hyperlipidaemia | 13,175 | 811 | 0.776 | 0.925 | 0.900 | 1.007 | 0.911 | 1.010 |
Depression | 6,326 | 876 | 0.847 | 1.000 | 0.961 | 0.979 | 1.009 | 1.000 |
Diabetes | 5,724 | 1,180 | 0.714 | 1.000 | 0.774 | 0.984 | 0.793 | 1.000 |
Asthma | 4,090 | 522 | 0.951 | 1.000 | 0.921 | 0.959 | 0.986 | 1.000 |
CHF | 864 | 1,396 | 1.031 | 1.000 | 0.755 | 0.958 | 0.774 | 1.000 |
Drug utilisation groups | ||||||||
Antihypertensives | 18,209 | 990 | 0.721 | 0.918 | 0.856 | 1.000 | 0.859 | 1.000 |
Lipid-lowering | 9,912 | 1,084 | 0.638 | 0.811 | 0.843 | 1.000 | 0.853 | 1.000 |
Antidepressants | 8,717 | 1,023 | 0.646 | 0.774 | 0.920 | 1.000 | 0.936 | 1.000 |
Antidiabetics | 4,947 | 1,267 | 0.654 | 0.917 | 0.785 | 0.998 | 0.797 | 1.002 |
Antiasthmatics | 7,303 | 755 | 0.716 | 0.820 | 0.870 | 1.000 | 0.874 | 1.000 |
CHF | 3,981 | 1,349 | 0.687 | 0.822 | 0.773 | 1.000 | 0.774 | 1.000 |
Year-1 spending percentiles | ||||||||
Highest 1% | 841 | 5,708 | 0.175 | 0.240 | 0.247 | 0.345 | 0.249 | 0.368 |
Highest 5% | 4,207 | 3,026 | 0.301 | 0.421 | 0.419 | 0.548 | 0.421 | 0.572 |
Highest 10% | 8,415 | 2,221 | 0.378 | 0.519 | 0.517 | 0.642 | 0.519 | 0.665 |
Highest 30% | 25,245 | 1,168 | 0.582 | 0.736 | 0.735 | 0.835 | 0.738 | 0.846 |
Highest 50% | 42,075 | 766 | 0.746 | 0.859 | 0.882 | 0.935 | 0.886 | 0.938 |